Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.28ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.28SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JN.1.18ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.18SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JN.1.29ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.29SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JN.1.7.2ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.7.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
KV.2ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
KV.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
XBB.1.16.15ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
XBB.1.16.15SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
JN.1.39ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.39SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JN.2ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JN.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JD.1.1.6ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JD.1.1.6SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
HK.3.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
HK.3.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
JN.1.9ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.9SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F1233.44Japan
JN.1.7ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.7SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JN.1.43ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.43SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JN.1.21ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.21SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JC.5.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JC.5.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
XDPORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
XDPSWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
KP.3ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
KP.3SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
KP.3.3.2ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
KP.3.3.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
KP.2.3.3ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
KP.1.1.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
LB.1.3ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
LB.1.3SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
KP.3.3.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
KP.3.3.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
XDYORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
XDYSWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
JN.1.18.4ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.1.18.4SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
KP.4.1.3ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
KP.4.1.3SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used